Patient Support

Patient Insurance Support

Provide your patients with access to insurance support with the organizations and programs listed below.

Caring Voice Coalition

Caring Voice Coalition is a nonprofit organization that provides counseling and advocacy services for people affected by chronic illness. Through their Insurance Counseling and Advocacy Program, Caring Voice provides assistance with billing and reimbursement issues.

For more information about all the ways that Caring Voice can help, visit www.caringvoice.org or call 1-888-267-1440.

Patient Services Incorporated (PSI)

PSI is a national nonprofit organization committed to helping people with expensive chronic illnesses and conditions by locating health insurance solutions and assisting with premiums and prescription co-payments.

www.uneedpsi.org
Phone:  1-800-366-7741

Prolastin Direct^SM

Prolastin Direct^SM not only delivers Prolastin^® when and where your patients need it, it also provides insurance assistance and support. Have your patients call 1-800-305-7881 to get started. You can also visit www.prolastindirect.com for more information.

Reimbursement Assistance

For personalized assistance with coding, reimbursement and coverage questions, Talecris offers the Talecris Reimbursement HelpLine. The Talecris Reimbursement HelpLine provides information regarding reimbursement policies, billing procedures, coding, and claim appeals for Talecris Biotherapeutics, including Prolastin^®. The service is free, and reimbursement experts are available to assist Talecris customers Monday through Friday from 8:30 a.m. to 5:30 p.m. (Eastern Time) by calling 1-800-288-8374.

Talecris Reimbursement HelpLine:
1-800-288-8374

Monday - Friday
8:30 am to 5:30 pm (Eastern Time)

Important Safety Information

Prolastin^®, Alpha₁-Proteinase Inhibitor (Human) is indicated for chronic replacement therapy of individuals having congenital deficiency of alpha-1 PI (alpha₁-antitrypsin deficiency) with clinically demonstrable panacinar emphysema. Weekly Prolastin^® therapy has demonstrated a low occurrence of side effects. In clinical studies with Prolastin^®, reactions were observed in 1.16% of infusions, the most common events being fever (0.77%), light-headedness (0.19%), and dizziness (0.19%). As with all plasma-derived therapeutics, the potential to transmit infectious agents cannot be totally eliminated. Individuals with selective IgA deficiencies who have known antibody against IgA (anti-IgA antibody) should not receive Prolastin^®, since these patients may experience severe reactions, including anaphylaxis, to IgA which may be present.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please click here for Prolastin^® full Prescribing Information.

Remember, your doctor or healthcare provider is the single best source of information regarding you and your health. Please consult your doctor or healthcare provider if you have any questions about your health or any of your medications.